The forecasted Tuberculosis treatment success rate in India shows a steady increase from 88% in 2024 to 89% from 2025 onwards, indicating a positive trend. Compared to the 2023 success rate of 87%, there is a marginal yet significant improvement. The year-on-year variation from 2023 to 2024 is approximately 1.15%, with stability expected through to 2028. Given this trend, the 5-year Compound Annual Growth Rate (CAGR) maintains a consistent upward trajectory, reflecting efforts in enhancing TB treatment efficacy in India.
Future trends to monitor include:
- The impact of new treatment protocols and technologies on success rates.
- Government policies enhancing access to TB care in rural and urban areas.
- The influence of healthcare infrastructure improvements on treatment outcomes.
